Related Experiment Videos
Early bacterial infections in lung transplant recipients
Abstract:
Early bacterial pulmonary infections within 2 weeks after lung transplantation were studied in 29 patients undergoing surgery between December 1989 and May 1992. Suspected pulmonary infections occurred in 11 patients (38 percent). The most common bacterial organisms isolated were Klebsiella pneumoniae (45 percent; 5/11), Pseudomonas aeruginosa (36 percent; 4/11), Escherichia coli (27 percent; 3/11), Staphylococcus aureus (18 percent; 2/11), and Enterobacter cloacae (18 percent; 2/11). The mortality due to infection was 3 percent (1/29) in the early postoperative period. None of the following variables was found to be of prognostic significance: positive donor cultures, ischemic time of the graft, use of cardiopulmonary bypass, number of courses of methylprednisolone for acute rejection, duration of postoperative intubation, and type of surgical procedure. The presence of infection in the early postoperative period did not influence long-term survival. In the absence of prognostic parameters, prompt adjustment of antibiotic therapy to the results of antibiograms remains the most important therapeutic step in the management of infections in the early postoperative period after lung transplantation.
Insights
Early bacterial lung infections after lung transplantation are common, with Klebsiella pneumoniae and Pseudomonas aeruginosa being frequent culprits. Prompt antibiotic adjustment based on antibiograms is crucial for managing these infections and ensuring long-term survival.
Area of Science:
- Medicine
- Infectious Diseases
- Pulmonology
Background:
- Early bacterial pulmonary infections pose a significant risk following lung transplantation.
- Understanding the common pathogens and risk factors is vital for patient management.
Purpose of the Study:
- To investigate the incidence, causative organisms, and prognostic factors of early bacterial pulmonary infections after lung transplantation.
- To evaluate the impact of these infections on long-term patient survival.
Main Methods:
- Retrospective study of 29 lung transplant recipients between December 1989 and May 1992.
- Analysis of suspected pulmonary infections, isolated bacterial organisms, and patient outcomes.
- Evaluation of potential prognostic variables including donor cultures, graft ischemia time, and immunosuppression.
Main Results:
- 38% of patients developed suspected infections within 2 weeks post-transplant.
- Common pathogens included Klebsiella pneumoniae (45%), Pseudomonas aeruginosa (36%), and Escherichia coli (27%).
- Early infection did not significantly impact long-term survival, and no specific prognostic factors were identified.
Conclusions:
- Prompt antibiotic therapy tailored to antibiogram results is the most critical management strategy for early post-lung transplant bacterial infections.
- Despite early infectious complications, long-term survival is not adversely affected by the presence of infection.